← Open Payments lookup

KEVIN SIEWERS: Open Payments

NPI 1215056221 · DENVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$38,945 in 108 payments from 10 companies in 2025. Trend: 2023 $44,517 · 2024 $62,594 · 2025 $38,945

Speaker / faculty: $26,133Consulting: $5,625Food & beverage: $3,605Travel & lodging: $3,583
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.35$22,872
Otsuka America Pharmaceutical, Inc.26$8,102
Teva Pharmaceuticals USA, Inc.21$6,918
Alkermes, Inc.10$283
E.R. Squibb & Sons, L.L.C.6$263
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$225
Otsuka Pharmaceutical Development & Commercialization, Inc.1$105
Janssen Scientific Affairs, LLC1$88
Lundbeck LLC3$71
Janssen Pharmaceuticals, Inc1$19

Products named: INGREZZA, ABILIFY MAINTENA, UZEDY, REXULTI, ABILIFY ASIMTUFII, COBENFY, CAPLYTA, ARISTADA.

Industry payments across NJ — which companies pay providers there.